Circulating bone morphogenetic protein 10 as a novel marker of atrial stress and remodelling in heart failure
BMP10 emerges as a novel biomarker reflecting atrial stress and remodelling in chronic HF patients. Its additional predictive value for adverse outcomes underscores its potential utility in enhancing risk stratification and guiding therapeutic interventions in HF management.
Authors
- Rudolf A. de Boer (ORCID: https://orcid.org/0000-0002-4775-9140)
- Navin Suthahar (ORCID: https://orcid.org/0000-0002-7781-2897)
- Daan C H Ceelen (ORCID: https://orcid.org/0000-0003-1670-2165)
- Peter Kastner (ORCID: https://orcid.org/0000-0001-8744-7152)
- Valentina Bračun (ORCID: https://orcid.org/0009-0009-1850-1886)
- Bart J. van Essen (ORCID: https://orcid.org/0000-0002-9057-7449)
- Chim C. Lang (ORCID: https://orcid.org/0000-0002-4530-3078)
- Adriaan A. Voors (ORCID: https://orcid.org/0000-0002-5417-4415)
- Jozine M. ter Maaten (ORCID: https://orcid.org/0000-0002-4910-9336)
- Serge Masson (ORCID: https://orcid.org/0000-0002-1446-0281)
Institutions
- Roche (Switzerland) (CH)
- University of Groningen (NL)
- Erasmus MC (NL)
- Ninewells Hospital (GB)
- Roche Pharma AG (Germany) (DE)
- National University of Malaysia (MY)
Publication Details
- Journal
- Heart
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1136/heartjnl-2024-324486
- Citations
- 9
- Primary Topic
- GDF15 and Related Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 4.23
Funders
- European Commission
- Hartstichting
- European Research Council